BioXcel Therapeutics (BTAIQ) Finished Goods (2022 - 2026)
BioXcel Therapeutics' Finished Goods came in at $75,000 for Q2 2026, up 2.7% from $73,000 a year earlier but down 18.5% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Finished Goods (2022 - 2026) Analysis & Trends
At the end of FY2025, BioXcel Therapeutics' Finished Goods was $37,000, down 78.6% from FY2024.
- Finished Goods has declined in each of the last three years, with a three-year compound annual growth rate of -60.4% (FY2022 to FY2025).
- Going back by year, Finished Goods was $173,000 in FY2024 (-57.3%), $405,000 in FY2023 (-31.9%) and $595,000 in FY2022.
- The five-year range for quarterly Finished Goods is $37,000 (Q4 2025) to $1.45 million (Q2 2024).
- Year-over-year, Finished Goods increased in 1 of the last eight quarters, with an average decline of 57.3%.
- The fastest year-over-year change in Finished Goods over five years came in Q2 2023 (growth of 314.3%), and the weakest in Q2 2025 (a decline of 95.0%).
- Business Quant data shows BTAIQ's Finished Goods at $92,000 (Q1 2026), $37,000 (Q4 2025) and $65,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 692,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 405,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 595,000.00 |
| Sep 30, 2022 | 604,000.00 |
| Jun 30, 2022 | 300,000.00 |
API Access
BioXcel Therapeutics Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();